Status:
COMPLETED
Assessment of Gastric Motility on Funtional Dyspepsia and Joint Hypermobility Syndrome
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Functional Dyspepsia
Joint Hypermobility Syndrome
Eligibility:
All Genders
18-70 years
Brief Summary
Functional dyspepsia (FD) is defined as the presence of gastroduodenal symptoms in the absence of organic disease that is likely to explain the symptoms. Joint hypermobility (JH) refers to the increas...
Eligibility Criteria
Inclusion
- \- Patients with PDS diagnosis as per Rome III by Rome III questionnaire
Exclusion
- Patients are excluded from the study if any of the following criteria are met:
- Females who are pregnant or lactating.
- Patients who are H. Pylori positive
- Patients with confirmed gastro-intestinal disease, with former digestive surgery affecting upper gut motility, a concomitant disease responsible for digestive symptoms
- Patients presenting with predominant symptoms of irritable bowel syndrome (IBS), CIN or GERD.
Key Trial Info
Start Date :
July 4 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2016
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT04279990
Start Date
July 4 2014
End Date
November 1 2016
Last Update
February 21 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.